Effect of High Versus Low-level Laser Therapy in Patients of Lumber Radiculopathy

January 28, 2024 updated by: Riphah International University
To Compare the effects of high-level laser therapy (HLLT) and low-level laser therapy (LLLT) on pain in patients with lumbar radiculopathy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Faisalābad, Punjab, Pakistan, 54000
        • Faiq Medical Complex
      • Faisalābad, Punjab, Pakistan, 54000
        • Independent University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients of both genders male and female will be included.
  • Patients aged 40-65 years will be included.
  • Patients with a diagnosis of lumbar radiculopathy confirmed by clinical evaluation by a physician or physiotherapist.
  • Patients with a history of radicular leg pain and/or numbness or tingling sensation in the leg.
  • a positive score on the Straight Leg Raise (pain between 35 degrees and 75 degrees), pain limiting functional ability, and scores at least 3/10 on the VAS, restricted lumbar range of motion - 25% flexion, 20% extension.
  • Patients who have not received any form of treatment for lumbar radiculopathy within the past 3 months

Exclusion Criteria:

  • Patients with a history of spinal surgery in the last 2 years or spinal deformity.
  • Patients with a history of fracture or dislocation of the lumbar spine.
  • Patients with a diagnosis of any other neurological disorder or neuropathy.
  • Patients who are pregnant or breastfeeding.
  • Patients with any other medical condition that may interfere i.e. inflammatory rheumatic disease, cardiac pacemaker, continuing that may interfere with the study outcomes or put them at risk with the study outcomes or put them at risk.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Level Laser Therapy
This group received High-level laser therapy along with conventional physiotherapy treatment 3 times per week for 6 weeks.
Other: High-level laser therapy
This group received High-level laser therapy along with conventional physiotherapy treatment 3 times per week for 6 weeks.
Experimental: Low Level Laser Therapy
This group received Low-level laser therapy along with conventional physiotherapy treatment 3 times per week for 6 weeks.
Other: Low-level laser therapy
This group received Low-level laser therapy along with conventional physiotherapy treatment 3 times per week for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Level
Time Frame: 6 weeks
Visual Analogue scale
6 weeks
Rang of motion
Time Frame: 6 weeks
Straight Leg Raise
6 weeks
Level of Disability
Time Frame: 6 weeks
Oswestry Disability Index (ODI)
6 weeks
To measure Quality of Life
Time Frame: 6 weeks
Health Questionnaire (EQ-5D-5L)
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Binash Afzal, PHD*, Riphah International University Lahore Campus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

October 10, 2023

Study Registration Dates

First Submitted

January 28, 2024

First Submitted That Met QC Criteria

January 28, 2024

First Posted (Estimated)

February 5, 2024

Study Record Updates

Last Update Posted (Estimated)

February 5, 2024

Last Update Submitted That Met QC Criteria

January 28, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR&AHS/23/0239

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Radiculopathy

Clinical Trials on High-level laser therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe